EC Number |
Recommended Name |
Source Tissue |
Reference |
---|
3.4.21.98 | hepacivirin |
blood plasma |
- |
707390 |
3.4.21.B1 | hyaluronan-binding serine protease |
blood plasma |
- |
691862, 692366, 710611, 717196, 718425, 731684, 752346, 752625, 755578, 755588 |
3.4.21.B10 | neurosin |
blood plasma |
- |
731704 |
3.4.21.B27 | proprotein convertase 7 |
blood plasma |
correlation between plasma levels of the soluble human transferrin receptor 1 and the PCSK7 gene |
731889 |
3.4.21.B28 | fibroblast activation protein alpha subunit |
blood plasma |
- |
678908, 691017, 718048 |
3.4.21.B4 | granzyme K |
blood plasma |
increased GzmK levels during viral infections |
668481 |
3.4.21.B45 | kallikrein 14 |
blood plasma |
- |
667860, 668566 |
3.4.21.B7 | mannan-binding lectin-associated serine protease 1 |
blood plasma |
- |
666927, 708697, 718281, 732518, 732519, 732520, 732522, 732693 |
3.4.21.B7 | mannan-binding lectin-associated serine protease 1 |
blood plasma |
immunohistochemic determination of enzyme levels in plasma samples and variations over time, MASP-1 levels after the induction of an acute-phase response by operation for colorectal cancer show an initial short decrease, concomitant with an increase in C-reactive protein levels, followed by an increase, doubling the MASP-1 concentration after 2 days, overview |
731673 |
3.4.22.1 | cathepsin B |
blood plasma |
- |
733217 |
3.4.22.15 | cathepsin L |
blood plasma |
- |
696963 |
3.4.22.27 | cathepsin S |
blood plasma |
- |
708138 |
3.4.22.56 | caspase-3 |
blood plasma |
- |
681528 |
3.4.22.61 | caspase-8 |
blood plasma |
the levels of caspase-3 and caspase-8 in plasma are both significantly higher than in sperm |
753880 |
3.4.22.62 | caspase-9 |
blood plasma |
- |
753880 |
3.4.22.B35 | calpain 15 |
blood plasma |
- |
754525 |
3.4.22.B72 | SENP3 peptidase |
blood plasma |
- |
755449 |
3.4.23.15 | renin |
blood plasma |
- |
668894, 677442, 679245, 681186, 711389, 711396, 711431, 711629, 711686, 711768, 711778, 711793, 711797, 711802, 711895, 711896, 712135, 712265, 712634, 712874, 712875, 712922, 712931, 717093, 717506, 717688 |
3.4.23.15 | renin |
blood plasma |
determination of plasma aldosterone-to-renin ratio thresholds in plasma of healthy persons, patients with hypertension and those with additional adrenal adenomas, overview |
669705 |
3.4.23.15 | renin |
blood plasma |
plasma renin activity is markedly reduced in preeclampsia |
678986 |
3.4.23.15 | renin |
blood plasma |
plasma renin activity, PRA, and active renin concentration, ARC, overview |
668473 |
3.4.23.5 | cathepsin D |
blood plasma |
- |
712050 |
3.4.24.11 | neprilysin |
blood plasma |
- |
667149, 753262 |
3.4.24.17 | stromelysin 1 |
blood plasma |
from Alzheimer disease patients and controls |
734785 |
3.4.24.24 | gelatinase A |
blood plasma |
- |
752865 |
3.4.24.34 | neutrophil collagenase |
blood plasma |
- |
718282 |
3.4.24.35 | gelatinase B |
blood plasma |
- |
699677, 707123, 708144, 708170, 708171, 708773, 708814, 709277, 709574, 710575, 710602 |
3.4.24.35 | gelatinase B |
blood plasma |
plasma active MMP-9 and TIMP-1 are measured at three time-points in 163 individuals, thereof 129 males and all with average age of 62.8 years. Active MMP-9 and TIMP-1 are similar irrespective of the months of the year the sample, and are thus independent of season and storage time |
717503 |
3.4.24.79 | pappalysin-1 |
blood plasma |
- |
754523 |
3.4.24.82 | ADAMTS-4 endopeptidase |
blood plasma |
from patients with stable effort angina pectoris, acute coronary syndromes and in controls. Higher levels of ADAMTS4 are found with progression of coronary artery disease from stable effort angina pectoris to unstable angina pectoris to non-ST-segment elevation acute myocardial infarction and to ST-segment elevation acute myocardial infarction |
707655 |
3.4.24.87 | ADAMTS13 endopeptidase |
blood plasma |
- |
650714, 669524, 670946, 677437, 678918, 678919, 678921, 678964, 678966, 679396, 680535, 680695, 680929, 681662, 681663, 682523, 682901, 682939, 719761, 719881, 720345, 720367, 735022, 735184, 754522, 755525, 755580, 755582, 755613, 755614 |
3.4.24.87 | ADAMTS13 endopeptidase |
blood plasma |
ADAMTS-13 activity in type 1, 2A, and 2B von Willebrand disease is higher than in healthy controls, but lower than in type 3 von Willebrand disease |
670948 |
3.4.24.87 | ADAMTS13 endopeptidase |
blood plasma |
ADAMTS13 activity decreases in a time-dependent manner during systemic inflammation |
670936 |
3.4.24.87 | ADAMTS13 endopeptidase |
blood plasma |
levels of ADAMTS13 are lower and levels of von Willebrand Factor are higher in young patients with cardiovascular disease compared to healthy individuals |
695967 |
3.4.24.87 | ADAMTS13 endopeptidase |
blood plasma |
no severe ADAMTS13 deficiency is detected in patients with sickle cell disease |
667122 |
3.4.24.87 | ADAMTS13 endopeptidase |
blood plasma |
of normal non-pregnant woman, pregnant and post-delivery women. Between the non-pregant state and the 6-11 week period of pregnancy, there is no statistical difference in the levels of ADAMTS13 activity. Starting from the 12-16 week, group differences become significant. the late postpartum shows the highest level of protease activity, including in the non-pregant state. In non-pregnant women, protease activity is significantly lower in nulliparous compared to parous women. In pregant and psot-delivery women, mean ADAMTS13 actrivity is slightly lower in primigravidae than in multigravidae |
670933 |
3.4.24.87 | ADAMTS13 endopeptidase |
blood plasma |
platelet-poor |
668076 |
3.4.24.87 | ADAMTS13 endopeptidase |
blood plasma |
von Willebrand factor-cleaving protease activity remains at the intermediate level in thrombotic thrombocytopenic purpura |
667102 |
3.4.24.B11 | ADAMTS1 endopeptidase |
blood plasma |
- |
677500 |
3.5.1.12 | biotinidase |
blood plasma |
- |
667185 |
3.5.1.12 | biotinidase |
blood plasma |
increased plasma biotinidase activity in rats with paracetamol-induced acute liver injury. The increase may serve as an indicator of paracetamol-induced acute liver injury in the rat |
668291 |
3.5.1.13 | aryl-acylamidase |
blood plasma |
- |
667330 |
3.5.1.26 | N4-(beta-N-acetylglucosaminyl)-L-asparaginase |
blood plasma |
- |
669745 |
3.5.1.28 | N-acetylmuramoyl-L-alanine amidase |
blood plasma |
- |
172023 |
3.5.1.92 | pantetheine hydrolase |
blood plasma |
- |
734998 |
3.5.3.1 | arginase |
blood plasma |
- |
686308, 688758, 752912 |
3.5.4.3 | guanine deaminase |
blood plasma |
- |
667182 |
3.5.4.4 | adenosine deaminase |
blood plasma |
- |
695585 |
3.5.4.4 | adenosine deaminase |
blood plasma |
isozyme ADA2 |
667870 |
3.5.4.5 | cytidine deaminase |
blood plasma |
glioblastoma multiforme (GBM) patients |
695606 |
3.6.1.18 | FAD diphosphatase |
blood plasma |
- |
209922 |
3.7.1.2 | fumarylacetoacetase |
blood plasma |
- |
670957 |
4.1.1.15 | glutamate decarboxylase |
blood plasma |
- |
697572 |
4.1.1.28 | aromatic-L-amino-acid decarboxylase |
blood plasma |
- |
663634, 702954 |
4.1.1.45 | aminocarboxymuconate-semialdehyde decarboxylase |
blood plasma |
- |
749404 |
4.1.1.90 | peptidyl-glutamate 4-carboxylase |
blood plasma |
coagulation assays |
696930 |
4.2.1.22 | cystathionine beta-synthase |
blood plasma |
- |
706002 |
4.2.1.24 | porphobilinogen synthase |
blood plasma |
- |
691169 |
4.2.1.24 | porphobilinogen synthase |
blood plasma |
plasma ALA level of the fatigued rats is slightly higher (approximately 1.4fold) than that of the control or food-restricted animals |
-, 677945 |
4.3.2.2 | adenylosuccinate lyase |
blood plasma |
- |
709392 |
4.4.1.1 | cystathionine gamma-lyase |
blood plasma |
- |
690377 |
5.3.3.12 | L-dopachrome isomerase |
blood plasma |
- |
747839 |
5.3.3.9 | prostaglandin-A1 DELTA-isomerase |
blood plasma |
- |
3027, 3028, 3029 |
7.6.2.4 | ABC-type fatty-acyl-CoA transporter |
blood plasma |
- |
689002 |